share_log

UBS Initiates Coverage on Pacific Biosciences of California With Neutral Rating, $13 Price Target

UBS Initiates Coverage on Pacific Biosciences of California With Neutral Rating, $13 Price Target

瑞银开始对加州太平洋生物科学进行报道,评级为中性,目标价为13美元
MT Newswires ·  2023/02/02 09:05

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发